These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18524330)

  • 1. [Validation of the PRIME-MD for the detection of generalized anxiety disorder].
    Mata S; González A; Lavie R; Resler G
    Invest Clin; 2008 Mar; 49(1):39-48. PubMed ID: 18524330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prevalence of generalized anxiety disorder and comorbidity among psychiatric outpatients].
    Ozcan M; Uğuz F; Cilli AS
    Turk Psikiyatri Derg; 2006; 17(4):276-85. PubMed ID: 17183444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: the GADIS II study (Generalized Anxiety and Depression Impact Survey II).
    Ansseau M; Fischler B; Dierick M; Albert A; Leyman S; Mignon A
    Depress Anxiety; 2008; 25(6):506-13. PubMed ID: 17595015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic severity of PRIME-MD diagnosed episodes of panic and generalized anxiety disorder in primary care.
    Rollman BL; Belnap BH; Mazumdar S; Zhu F; Kroenke K; Schulberg HC; Katherine Shear M
    J Gen Intern Med; 2005 Jul; 20(7):623-8. PubMed ID: 16050857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the GAD-7 (Malay version) among women attending a primary care clinic in Malaysia.
    Sidik SM; Arroll B; Goodyear-Smith F
    J Prim Health Care; 2012 Mar; 4(1):5-11, A1. PubMed ID: 22377544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry out-patient clinics in Spain. Results of the LIGANDO study].
    Caballero L; Bobes J; Vilardaga I; Rejas J
    Actas Esp Psiquiatr; 2009; 37(1):17-20. PubMed ID: 18815907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of common mental disorders by using PRIME-MD Patient Health Questionnaire.
    Avasthi A; Varma SC; Kulhara P; Nehra R; Grover S; Sharma S
    Indian J Med Res; 2008 Feb; 127(2):159-64. PubMed ID: 18403794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for mental disorders in cardiology outpatients.
    Birket-Smith M; Rasmussen A
    Nord J Psychiatry; 2008; 62(2):147-50. PubMed ID: 18569779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validation of the Spanish version of PRIME-MD: a procedure for diagnosing mental disorders in primary care].
    Baca E; Saiz J; Agüera L; Caballero L; Fernández-Liria A; Ramos J; Gil A; Madrigal M; Porras A
    Actas Esp Psiquiatr; 1999; 27(6):375-83. PubMed ID: 10611561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder.
    Etkin A; Prater KE; Schatzberg AF; Menon V; Greicius MD
    Arch Gen Psychiatry; 2009 Dec; 66(12):1361-72. PubMed ID: 19996041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of generalized anxiety disorder in Europe.
    Lieb R; Becker E; Altamura C
    Eur Neuropsychopharmacol; 2005 Aug; 15(4):445-52. PubMed ID: 15951160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized anxiety disorder, somatic pain and health care costs.
    Olfson M; Gameroff MJ
    Gen Hosp Psychiatry; 2007; 29(4):310-6. PubMed ID: 17591507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the Spanish version of the Mood Disorder Questionnaire to detect bipolar disorder type II in patients with major depression disorder].
    González A; Arias A; Mata S; Lima L
    Invest Clin; 2009 Jun; 50(2):163-71. PubMed ID: 19662812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-retest reliability of the PRIME-MD: limitations in diagnosing mental disorders in primary care.
    Bakker IM; Terluin B; van Marwijk HW; van Mechelen W; Stalman WA
    Eur J Public Health; 2009 Jun; 19(3):303-7. PubMed ID: 19181777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized anxiety disorder severity scale (GADSS): a preliminary validation study.
    Shear K; Belnap BH; Mazumdar S; Houck P; Rollman BL
    Depress Anxiety; 2006; 23(2):77-82. PubMed ID: 16411185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study.
    Seo JG; Cho YW; Lee SJ; Lee JJ; Kim JE; Moon HJ; Park SP
    Epilepsy Behav; 2014 Jun; 35():59-63. PubMed ID: 24798411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients.
    Bankier B; Barajas J; Martinez-Rumayor A; Januzzi JL
    Eur Heart J; 2008 Sep; 29(18):2212-7. PubMed ID: 18603621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of generalized anxiety disorder: epidemiology, presentation, and course.
    Weisberg RB
    J Clin Psychiatry; 2009; 70 Suppl 2():4-9. PubMed ID: 19371500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
    Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
    J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.